Pertussis Vaccine Acellular With Diphtheria And Tetanus Toxoids, Adsorbed
Recommended VaccinesRestrictedNot applicable line
Active immunisation against tetanus, diphtheria and pertussis in persons aged 10 years and over as a booster following primary immunisation.
2
Submissions
2006–06
On the record
—
ICER range
Cost-min
Cost basis
Access path
- Mar 2006Recommended · restricted
Evidence: RCT, Single-arm → RCT
- Mar 2006Recommended
Evidence: RCT, Single-arm → RCT
- PBS listing · Restricted
RecommendedDeferredNot recommended
Cost-effectiveness
Cost-minimisation analysis; no ICER calculated by design.
The PBAC accepted this analysis. PBAC · 2006
Decision context
PopulationAdolescents aged 10 to less than 18 years for active immunisation against tetanus, diphtheria and pertussis as a booster following primary immunisation.
Submission history
| Decided | Outcome | Comparator | ICER | Evidence |
|---|---|---|---|---|
| Mar 2006 | Recommended · restricted | Boostrix | — | RCT, Single-arm · Surrogate |
| Mar 2006 | Recommended | Boostrix | — | RCT |
Similar precedents
Diphtheria And Tetanus Toxoids Combined With Pertussis Vaccine-Acellular87%Pertussis Vaccine-Acellular, Combined With Diphtheria And Tetanus Toxoids (Dtap)81%Adacel78%Diphtheria, Tetanus, Acellular Pertussis Vaccine (Dtpa)74%Diphtheria + Tetanus + Acellular Pertussis Vaccine72%Diphtheria, Tetanus, Pertussis, Hepatitis B, Poliomyelitis And Haemophilus Influenzae Type B Conjugate Vaccine68%Human Rotavirus Vaccine65%Pneumococcal Polysaccharide Conjugate Vaccine64%